Target intelligence / Profile preview

Deleted in azoospermia-like (DAZL)

Target
DAZL
Molecular classification
RNA-binding protein, Other
01

Overview

Deleted in azoospermia-like (DAZL) is a germline-specific RNA-binding protein essential for gametogenesis in both males and females[3][5][7]. The protein localizes to the nucleus and cytoplasm in fetal and postnatal germ cells, and undergoes dynamic relocalization between nucleus and cytoplasm during stages of spermatogenesis and oogenesis[3][7]. DAZL acts as a regulator of translation, functioning as both repressor and activator of maternal and germ cell mRNAs, primarily by interacting with the poly(A)-binding proteins and directly binding to 3′ UTRs of many transcripts involved in germ cell development[1][2][5][6]. Disruption or mutation of the DAZL gene leads to severe spermatogenic failure and infertility, and in animal models, absence of DAZL impairs both expansion and differentiation of progenitor germ cells and can predispose to germ cell tumors[2][3][4][7]. DAZL is not considered a direct therapeutic target (such as a receptor or enzyme), but its function is critical for fertility and germline maintenance.

Other names
DAZHDAZL1DAZLASPGYLADAZ homologDAZ-like autosomalSPGY-like-autosomaldeleted in azoospermia-like 1germline specific RNA binding proteinspermatogenesis gene on the Y-like autosomaltestis secretory sperm-binding protein Li 204aMGC26406
02

Biological functions

Translation regulationGametogenesisGerm cell developmentMeiotic progressionmRNA stability
03

Disease associations

InfertilityPremature ovarian failureGerm cell tumor predisposition

Beyond the preview

Go deeper on Deleted in azoospermia-like (DAZL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deleted in azoospermia-like (DAZL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call